References
- Rea IM, Gibson DS, McGilligan V, McNerlan SE, Alexander HD, Ross OA. Age and age-related diseases: role of inflammation triggers and cytokines. Front Immunol. 2018;9:586. doi:10.3389/fimmu.2018.00586
- Franceschi C, Campisi J. Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. J Gerontol a Biol Sci Med Sci. 2014;69:S4–9. doi:10.1093/gerona/glu057
- Bektas A, Schurman SH, Sen R, Ferrucci L. Aging, inflammation and the environment. Exp Gerontol. 2018;105:10–18. doi:10.1016/j.exger.2017.12.015
- Sterpetti AV. Inflammatory cytokines and atherosclerotic plaque progression. Therapeutic implications. Curr Atheroscler Rep. 2020;22:75. doi:10.1007/s11883-020-00891-3
- Dhapola R, Hota SS, Sarma P, Bhattacharyya A, Medhi B, Reddy DH. Recent advances in molecular pathways and therapeutic implications targeting neuroinflammation for Alzheimer’s disease. Inflammopharmacology. 2021;29:1669–1681. doi:10.1007/s10787-021-00889-6
- Wang Z, Man MQ, Li T, Elias PM, Mauro TM. Aging-associated alterations in epidermal function and their clinical significance. Aging. 2020;12(6):5551–5565. doi:10.18632/aging.102946
- Parrish AR. The impact of aging on epithelial barriers. Tissue Barriers. 2017;5(4):e1343172. doi:10.1080/21688370.2017.1343172
- Yokoi A, Manabe M, Noto M, et al. Kampisho ni taisuru ryoshimbaisei kitosan yudotai haigo nyueki no hoshitsu koka [Moisturizing effect of emulsion containing partially myristoylated carboxylmethyl-chitosan applied to dry skin]. Hifu no kagaku. 2018;17:347–353. Japanese.
- Hu L, Mauro TM, Dang E, et al. Epidermal dysfunction leads to an age-associated increase in levels of serum inflammatory cytokines. J Invest Dermatol. 2017;137:1277–1285. doi:10.1016/j.jid.2017.01.007
- Seino H, Kawaguchi N, Arai Y, Ozawa N, Hamada K, Nagao N. Investigation of partially myristoylated carboxymethyl chitosan, an amphoteric-amphiphilic chitosan derivative, as a new material for cosmetic and dermal application. J Cosmet Dermatol. 2021;20(7):2332–2340. doi:10.1111/jocd.13833
- Ye L, Mauro TM, Dang E, et al. Topical applications of an emollient reduce circulating pro-inflammatory cytokine levels in chronically aged humans: a pilot clinical study. J Eur Acad Dermatol Venereol. 2019;33:2197–2201. doi:10.1111/jdv.15540
- Altunisik N, Kayhan Tetik B, Mete B. Evaluation of awareness regarding skin moisturisation and moisturiser usage frequency in individuals over 65 years of age. Australas J Ageing. 2020;39(4):e568–e572. doi:10.1111/ajag.12857
- Tsunemi Y, Kawashima M. Koreisha kanren shisetsu ni okeru hifu shikkan jittai chosa kekka [Results of a survey of skin diseases in facilities for elderly people]. Nihon rinsho hifukaikai zasshi. 2016;33(5):637–646. Japanese.
- Serup J. EEMCO guidance for the assessment of dry skin (xerosis) and ichthyosis: clinical scoring systems. Skin Res Technol. 1995;1(3):109–114. doi:10.1111/j.1600-0846.1995.tb00029.x
- Hahnel E, Blume-Peytavi U, Trojahn C, et al. The effectiveness of standardized skin care regimens on skin dryness in nursing home residents: a randomized controlled parallel-group pragmatic trial. Int J Nurs Stud. 2017;70:1–10. doi:10.1016/j.ijnurstu.2017.02.006
- Cardoso AL, Fernandes A, Aguilar-Pimentel JA, et al. Towards frailty biomarkers: candidates from genes and pathways regulated in aging and age-related diseases. Ageing Res Rev. 2018;47:214–277. doi:10.1016/j.arr.2018.07.004
- Moriya J. Critical roles of inflammation in atherosclerosis. J Cardiol. 2019;73:22–27. doi:10.1016/j.jjcc.2018.05.010
- Kany S, Vollrath JT, Relja B. Cytokines in inflammatory disease. Int J Mol Sci. 2019;20:6008. doi:10.3390/ijms20236008
- Salimi M, Barlow JL, Saunders SP, et al. A role for IL-25 and IL-33–driven type-2 innate lymphoid cells in atopic dermatitis. J Exp Med. 2013;210:2939–2950. doi:10.1084/jem.20130351
- Sehra S, Yao Y, Howell MD, et al. IL-4 regulates skin homeostasis and the predisposition toward allergic skin inflammation. J Immunol. 2010;184:3186–3190. doi:10.4049/jimmunol.0901860